(PharmaNewsWire.Com, March 01, 2019 ) MARKET INTRODUCTION A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. Majority of the sponsoring organizations do not have the requisite facilities and staff for conducting tests under special supervision and appropriate set-up for particular drugs and medical devices and thus choose to contract research of this kind.
MARKET DYNAMICS The pre-clinical CROs market is anticipated to grow in the forecast period owing to increasing budgets for early stage as well as rising adoption of outsourcing by pharmaceutical and medical device manufacturers. The market is likely to showcase opportunities for the new players with fastening drug and product approval procedures by the FDA and other regulatory bodies.
MARKET SCOPE The "Global Pre-Clinical CROs Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of pre-clinical CROs market with detailed market segmentation by service, end user, and geography. The global pre-clinical CROs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading pre-clinical CROs market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION The global pre-clinical CROs market is segmented on the basis of service, and end user. Based on service, the market is segmented as bioanalysis & DMPK studies, toxicology testing, and others. On the basis of end user, the global pre-clinical CROs market is segmented in to biopharmaceutical companies, government & academic institutes, and medical device companies.
REGIONAL FRAMEWORK The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global pre-clinical CROs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pre-clinical CROs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting pre-clinical CROs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the pre-clinical CROs market in these regions.
MARKET PLAYERS The reports cover key developments in the pre-clinical CROs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from pre-clinical CROs market are anticipated to lucrative growth opportunities in the future with the rising demand for pre-clinical CROs market in the global market. Below mentioned is the list of few companies engaged in the pre-clinical CROs market.
The report also includes the profiles of key pre-clinical CROs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Envigo Corporation Charles River Eurofins Scientific PRA Health Sciences, Inc Wuxi AppTec Medpace, Inc. Pharmaceutical Product Development, LLC. PAREXEL International Corporation ICON plc Laboratory Corporation of America Holdings
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
